Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2011(3): 509-516
DOI: 10.1055/s-0030-1258382
DOI: 10.1055/s-0030-1258382
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
Synthesis of (3S)- and (3R)-3-Hydroxy-β-ionone and Their Transformation into (3S)- and (3R)-β-Cryptoxanthin
Further Information
Received
17 October 2010
Publication Date:
23 December 2010 (online)
Publication History
Publication Date:
23 December 2010 (online)
Abstract
(3R)-3-Hydroxy-β-ionone and (3S)-3-hydroxy-β-ionone were synthesized in high enantiomeric purity from commercially available (±)-α-ionone. These ionones were then transformed into (3R)-β-cryptoxanthin and (3S)-β-cryptoxanthin by a C15+C10+C15 Wittig coupling strategy according to known methods. This methodology can considerably simplify the total synthesis of optically active carotenoids with 3-hydroxy-β-end groups that possess significant biological activities.
Key words
hydroxycarotenoids - carotenoid precursors - chiral resolution - stereoselective synthesis - Wittig reaction
- 1
Khachik F. Pure Appl. Chem. 2006, 78: 1551 - 2
Khachik F.Moura FF.Zhao DY.Aebischer CP.Bernstein PS. J. Invest. Ophthalmol. Vis. Sci. 2002, 43: 3383 - 3
Khachik F.London E.Moura FF.Johnson M.Steidl S.DeTolla L.Shipley S.Sanchez R.Chen XQ.Flaws J.Lutty G.McLeod S.Fowler B. J. Invest. Ophthalmol. Vis. Sci. 2006, 47: 5476 - 4
Bernstein PS.Khachik F.Carvalho LS.Muir GJ.Zhao DY.Katz NB. Exper. Eye Res. 2001, 72: 215 - 5
Kritchevsky SB.Bush AJ.Pahor M.Gross MD.
J. Epidemiol. 2000, 152: 1065 - 6
Yamaguchi M.Uchiyama S. Biol. Pharm. Bull. 2003, 26: 1188 - 7
Isler O.Lindler H.Montavon M.Ruegg R.Saucy G.Zeller P. Helv. Chim. Acta 1957, 40: 456 - 8
Loeber DE.Russell SW.Toube TP.Weedon BCL.Diment J. J. Chem. Soc. C 1971, 404 - 9
Rüttimann A.Mayer H. Helv. Chim. Acta 1980, 63: 1456 -
10a
Widmer E.Soukup M.Zell R.Broger E.Wagner HP.Imfeld M. Helv. Chim. Acta 1990, 73: 861 -
10b
Soukup M.Widmer E.Lukac T. Helv. Chim. Acta 1990, 73: 868 - 11
Pfander H.Semadeni PA. Aust. J. Chem. 1995, 48: 145 - 12
Marwah P.Marwah A.Lardy HA. Green Chem. 2004, 6: 570 -
13a
Prelog V.Osgan M. Helv. Chim. Acta 1952, 35: 986 -
13b
Widmer E.Soukup M.Zell R.Broger E.Lohri B.Marbet R.Lukac T. Helv. Chim. Acta 1982, 65: 944 -
13c
Yang M.Peng QR.Lan JB.Song GF.Xie RG. Synlett 2006, 2617 - 14
Ellis PR.Faruk AE.Moss GP.Weedon BCL. Helv. Chim. Acta 1981, 64: 1092 - 15
Broom SJ.Ede RM.Wilkins AL. Tetrahedron Lett. 1992, 33: 3197 - 16
Findlay JA.Mackay WD. Can. J. Chem. 1971, 49: 2369 - 17
Khachik F.Chang AN. J. Org. Chem. 2009, 74: 3875 - 18
Paust J.Reif W.Schuhmacher H. Justus Liebigs Ann. Chem. 1976, 2194 -
19a
Mayer H.Rüttiman A. Helv. Chim. Acta 1980, 63: 1451 -
19b
D’Abrosca B.Della Greca M.Fiorentino A.Monaco P.Oriano P.Temussi F. Phytochemistry 2004, 65: 497 - 20
Khachik F.Chang AN.Gana A.Mazzola E. J. Nat. Prod. 2007, 70: 220
References
Current address: Martek Biosciences Corporation, 6480 Dobbin Road, Columbia, MD 21045, USA; E-mail: achang@martek.com.